drugset / Trial / NCT00984360
Study of Naltrexone for Methamphetamine Addiction
Non-randomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether methamphetamine-dependent individuals will use less methamphetamine when treated with naltrexone. The study will also investigate whether individuals with the mu opioid receptor gene variant A118G will use less methamphetamine than individuals without A118G.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-07
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 380 mg | Intramuscular |